vs

Side-by-side financial comparison of LandBridge Co LLC (LB) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.

VIEMED HEALTHCARE, INC. is the larger business by last-quarter revenue ($76.2M vs $56.8M, roughly 1.3× LandBridge Co LLC). LandBridge Co LLC runs the higher net margin — 14.2% vs 7.4%, a 6.8% gap on every dollar of revenue. On growth, LandBridge Co LLC posted the faster year-over-year revenue change (55.6% vs 25.5%). LandBridge Co LLC produced more free cash flow last quarter ($122.0M vs $9.7M). Over the past eight quarters, LandBridge Co LLC's revenue compounded faster (72.8% CAGR vs 22.7%).

Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.

LB vs VMD — Head-to-Head

Bigger by revenue
VMD
VMD
1.3× larger
VMD
$76.2M
$56.8M
LB
Growing faster (revenue YoY)
LB
LB
+30.0% gap
LB
55.6%
25.5%
VMD
Higher net margin
LB
LB
6.8% more per $
LB
14.2%
7.4%
VMD
More free cash flow
LB
LB
$112.3M more FCF
LB
$122.0M
$9.7M
VMD
Faster 2-yr revenue CAGR
LB
LB
Annualised
LB
72.8%
22.7%
VMD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
LB
LB
VMD
VMD
Revenue
$56.8M
$76.2M
Net Profit
$8.1M
$5.6M
Gross Margin
57.9%
Operating Margin
60.0%
11.0%
Net Margin
14.2%
7.4%
Revenue YoY
55.6%
25.5%
Net Profit YoY
-83.7%
30.7%
EPS (diluted)
$0.24
$0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LB
LB
VMD
VMD
Q4 25
$56.8M
$76.2M
Q3 25
$50.8M
$71.9M
Q2 25
$47.5M
$63.1M
Q1 25
$44.0M
$59.1M
Q4 24
$36.5M
$60.7M
Q3 24
$28.5M
$58.0M
Q2 24
$26.0M
$55.0M
Q1 24
$19.0M
$50.6M
Net Profit
LB
LB
VMD
VMD
Q4 25
$8.1M
$5.6M
Q3 25
$8.1M
$3.5M
Q2 25
$7.5M
$3.2M
Q1 25
$6.5M
$2.6M
Q4 24
$49.3M
$4.3M
Q3 24
$2.7M
$3.9M
Q2 24
$-57.7M
$1.5M
Q1 24
$10.8M
$1.6M
Gross Margin
LB
LB
VMD
VMD
Q4 25
57.9%
Q3 25
57.5%
Q2 25
58.3%
Q1 25
56.3%
Q4 24
59.5%
Q3 24
59.3%
Q2 24
59.8%
Q1 24
58.9%
Operating Margin
LB
LB
VMD
VMD
Q4 25
60.0%
11.0%
Q3 25
60.8%
7.8%
Q2 25
60.0%
8.1%
Q1 25
57.0%
6.5%
Q4 24
49.4%
10.6%
Q3 24
11.2%
9.7%
Q2 24
-197.4%
6.6%
Q1 24
71.1%
4.4%
Net Margin
LB
LB
VMD
VMD
Q4 25
14.2%
7.4%
Q3 25
15.9%
4.9%
Q2 25
15.8%
5.0%
Q1 25
14.7%
4.4%
Q4 24
135.2%
7.1%
Q3 24
9.3%
6.7%
Q2 24
-222.1%
2.7%
Q1 24
56.7%
3.2%
EPS (diluted)
LB
LB
VMD
VMD
Q4 25
$0.24
$0.14
Q3 25
$0.26
$0.09
Q2 25
$0.24
$0.08
Q1 25
$0.20
$0.06
Q4 24
$0.10
Q3 24
$-0.04
$0.10
Q2 24
$0.04
Q1 24
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LB
LB
VMD
VMD
Cash + ST InvestmentsLiquidity on hand
$30.7M
$13.5M
Total DebtLower is stronger
$570.7M
Stockholders' EquityBook value
$340.3M
$141.5M
Total Assets
$1.4B
$199.2M
Debt / EquityLower = less leverage
1.68×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LB
LB
VMD
VMD
Q4 25
$30.7M
$13.5M
Q3 25
$28.3M
$11.1M
Q2 25
$20.3M
$20.0M
Q1 25
$14.9M
$10.2M
Q4 24
$37.0M
$17.5M
Q3 24
$14.4M
$11.3M
Q2 24
$24.6M
$8.8M
Q1 24
$7.3M
Total Debt
LB
LB
VMD
VMD
Q4 25
$570.7M
Q3 25
$366.1M
Q2 25
$370.9M
Q1 25
$375.5M
Q4 24
$385.5M
Q3 24
$242.4M
Q2 24
$360.8M
Q1 24
Stockholders' Equity
LB
LB
VMD
VMD
Q4 25
$340.3M
$141.5M
Q3 25
$272.0M
$133.6M
Q2 25
$266.4M
$139.7M
Q1 25
$217.0M
$134.8M
Q4 24
$211.8M
$131.4M
Q3 24
$97.2M
$125.0M
Q2 24
$296.4M
$119.4M
Q1 24
$162.3M
$116.3M
Total Assets
LB
LB
VMD
VMD
Q4 25
$1.4B
$199.2M
Q3 25
$1.1B
$202.4M
Q2 25
$1.1B
$184.6M
Q1 25
$1.0B
$178.1M
Q4 24
$1.0B
$177.1M
Q3 24
$689.9M
$169.5M
Q2 24
$710.5M
$163.9M
Q1 24
$154.9M
Debt / Equity
LB
LB
VMD
VMD
Q4 25
1.68×
Q3 25
1.35×
Q2 25
1.39×
Q1 25
1.73×
Q4 24
1.82×
Q3 24
2.49×
Q2 24
1.22×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LB
LB
VMD
VMD
Operating Cash FlowLast quarter
$126.3M
$18.4M
Free Cash FlowOCF − Capex
$122.0M
$9.7M
FCF MarginFCF / Revenue
214.9%
12.7%
Capex IntensityCapex / Revenue
7.5%
11.5%
Cash ConversionOCF / Net Profit
15.68×
3.27×
TTM Free Cash FlowTrailing 4 quarters
$207.7M
$11.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LB
LB
VMD
VMD
Q4 25
$126.3M
$18.4M
Q3 25
$34.9M
$18.4M
Q2 25
$37.3M
$12.3M
Q1 25
$15.9M
$2.9M
Q4 24
$67.6M
$15.0M
Q3 24
$7.5M
$12.7M
Q2 24
$16.0M
$10.2M
Q1 24
$17.2M
$1.2M
Free Cash Flow
LB
LB
VMD
VMD
Q4 25
$122.0M
$9.7M
Q3 25
$33.7M
$10.7M
Q2 25
$36.1M
$4.1M
Q1 25
$15.8M
$-12.6M
Q4 24
$66.7M
$3.2M
Q3 24
$7.1M
$1.7M
Q2 24
$15.7M
$1.2M
Q1 24
$17.1M
$-4.8M
FCF Margin
LB
LB
VMD
VMD
Q4 25
214.9%
12.7%
Q3 25
66.3%
14.9%
Q2 25
75.9%
6.5%
Q1 25
36.0%
-21.4%
Q4 24
182.6%
5.2%
Q3 24
25.1%
3.0%
Q2 24
60.4%
2.3%
Q1 24
90.1%
-9.5%
Capex Intensity
LB
LB
VMD
VMD
Q4 25
7.5%
11.5%
Q3 25
2.3%
10.6%
Q2 25
2.6%
12.9%
Q1 25
0.2%
26.2%
Q4 24
2.7%
19.5%
Q3 24
1.1%
19.0%
Q2 24
1.4%
16.3%
Q1 24
0.5%
11.9%
Cash Conversion
LB
LB
VMD
VMD
Q4 25
15.68×
3.27×
Q3 25
4.31×
5.23×
Q2 25
4.98×
3.88×
Q1 25
2.46×
1.09×
Q4 24
1.37×
3.47×
Q3 24
2.80×
3.29×
Q2 24
6.94×
Q1 24
1.60×
0.73×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons